Table 1 Socio-demographic data and pharmacological treatment of the sample at baseline and follow-up (N= 66)
Sample characteristics | Baseline | Follow-up | ||
|---|---|---|---|---|
n | % | n | % | |
Sex | ||||
Male | 24 | 36.4% | 24 | 36.4% |
Female | 42 | 63.6% | 42 | 63.6% |
Disease | ||||
Ulcerative colitis | 41 | 62.1% | 41 | 62.1% |
Crohn’s disease | 25 | 37.9% | 25 | 37.9% |
Marital status | ||||
Single | 23 | 34.8% | 19 | 28.8% |
Married | 39 | 59.1% | 43 | 65.2% |
Divorced | 4 | 6.1% | 4 | 6.1% |
Widowed | 0 | 0 | 0 | 0 |
Employment status | ||||
Retired | 7 | 10.6% | 13 | 19.7% |
Manual labor | 23 | 34.8% | 15 | 22.7% |
Sedentary work | 30 | 45.5% | 30 | 45.5% |
Unemployed | 6 | 9.1% | 8 | 12.1% |
Education | ||||
Primary school certificate | 0 | 0 | 0 | 0 |
8th grade diploma | 21 | 31.8% | 19 | 28.8% |
Diploma | 28 | 42.4% | 30 | 45.5% |
Bachelor’s degree | 5 | 7.6% | 3 | 4.5% |
Master degree | 10 | 15.2% | 12 | 18.2% |
PhD | 2 | 3% | 2 | 3% |
Pharmacological Treatment | ||||
Antidepressants | 7 | 10.6% | 4 | 6.1% |
TCA | 0 | 0 | 1 | 1.5% |
SSRI | 5 | 7.6% | 2 | 3% |
Other antidepressants | 2 | 3% | 1 | 1.5% |
Antipsychotics | 0 | 0 | 1 | 1.5% |
Anxiolytics | 5 | 7.6% | 2 | 3% |
Azathiaprina | 4 | 6.1% | 2 | 3% |
Biological | 3 | 4.5% | 21 | 31.8% |
Cortisone | 7 | 10.6% | 10 | 15.2% |
Mesalazine | 57 | 86.4% | 44 | 66.7% |
Anticoagulant | 2 | 3% | 4 | 6.1% |
Antidyslipidemics | 2 | 3% | 7 | 10.6% |
Antidiabetics | 1 | 1.5% | 0 | 0 |
Antihypertensive | 8 | 12.1% | 8 | 12.1% |